01 2DELAFLOXACIN MEGLUMINE
02 2ORITAVANCIN DIPHOSPHATE
01 2MELINTA
02 2MELINTA THERAP
01 3POWDER;INTRAVENOUS
02 1TABLET;ORAL
01 1EQ 1.2GM BASE/VIAL
02 1EQ 300MG BASE/VIAL
03 1EQ 400MG BASE/VIAL
04 1EQ 450MG BASE
01 4USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BAXDELA
Dosage Strength : EQ 450MG BASE
Packaging :
Approval Date : 2017-06-19
Application Number : 208610
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;INTRAVENOUS
Brand Name : BAXDELA
Dosage Strength : EQ 300MG BASE/VIAL
Packaging :
Approval Date : 2017-06-19
Application Number : 208611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;INTRAVENOUS
Brand Name : ORBACTIV
Dosage Strength : EQ 400MG BASE/VIAL
Packaging :
Approval Date : 2014-08-06
Application Number : 206334
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;INTRAVENOUS
Brand Name : KIMYRSA
Dosage Strength : EQ 1.2GM BASE/VIAL
Packaging :
Approval Date : 2021-03-12
Application Number : 214155
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?